Invesco Biotechnology & Genome ETF PBE
97.88 USD -0.55 (-0.56%)
At closeNov 13, 2026, 4:00 PM EST
97.88 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
97.38 Day range 98.16
75.50 52-week range 104.69
- YTD
- +19.15%
- 1 year
- +26.07%
News
benzinga.com Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets Cathie Wood’s ARKG bought Ionis, Beam, Veracyte and Scribe Therapeutics. Here are the biotech ETFs that also hold her latest bets.
benzinga.com Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval…
benzinga.com Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug.
benzinga.com New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this…
benzinga.com Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating…
benzinga.com FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits - benzinga.com US Judge Weighs Nationwide Ban On Abortion Pills U.S. District Judge Matthew Kacsmaryk questioned President Joe Biden's administration lawyers on whether the federal regulatory approval of the abortion pill mifepristone was proper. The judge is…
benzinga.com FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' - benzinga.com 5 Top ETFs With Exposure To Biogen For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA.
benzinga.com 3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when AstraZeneca (NYSE: AZN) announced a- benzinga.com 3 Health Care ETFs Where Components Are Enduring Downgrades After setting scintillating paces earlier this thanks to the race to develop a coronavirus vaccine, some health care exchange-traded funds are languishing.
benzinga.com Heaps Of Healthy Health Care ETFs 
benzinga.com Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy - benzinga.com Biotech And Natural Gas ETFs On A Roll
- benzinga.com Biotech Breakout Highlights Flawed ETF Thinking
- benzinga.com Interesting Similarities Among 2013's Top-Performing ETFs
- benzinga.com Under The Hood: An Unheralded Biotech ETF
- benzinga.com 4 Health Care ETFs Your Broker Forgot to Mention
- benzinga.com 3 Unheralded ETFs Up More Than 10% in the Past 90 Days (PBE, TAGS)
- benzinga.com Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)
- benzinga.com The Definitive Biotech ETF Guide (IBB, XBI, FBT)
- benzinga.com Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)
- benzinga.com Five Health Care ETFs Your Broker Forget To Mention
- benzinga.com ETFs For Biotech M&A Mania
- benzinga.com Five Biotech ETFs, Which One Is Worth A Look?